Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 2007, 57 (1): 43-66.
Article
PubMed
Google Scholar
Cannistra SA: Cancer of the ovary. N Engl J Med. 2004, 351 (24): 2519-2529. 10.1056/NEJMra041842.
Article
CAS
PubMed
Google Scholar
Bookman MA, Greer BE, Ozols RF: Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs. cisplatin and paclitaxel (GOG 158) and an update on GOG0 182-ICON5. Int J Gynecol Cancer. 2003, 13 (6): 735-740. 10.1111/j.1525-1438.2003.13602.x.
Article
CAS
PubMed
Google Scholar
Parmar MK, Ledermann JA, Colombo N, du Bois A, Delaloye JF, Kristensen GB, Wheeler S, Swart AM, Qian W, Torri V, et al: Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet. 2003, 361 (9375): 2099-2106. 10.1016/S0140-6736(03)13718-X.
Article
CAS
PubMed
Google Scholar
Sakamoto M, Kondo A, Kawasaki K, Goto T, Sakamoto H, Miyake K, Koyamatsu Y, Akiya T, Iwabuchi H, Muroya T, et al: Analysis of gene expression profiles associated with cisplatin resistance in human ovarian cancer cell lines and tissues using cDNA microarray. Hum Cell. 2001, 14 (4): 305-315.
CAS
PubMed
Google Scholar
Roberts D, Schick J, Conway S, Biade S, Laub PB, Stevenson JP, Hamilton TC, O'Dwyer PJ, Johnson SW: Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells. Br J Cancer. 2005, 92 (6): 1149-1158. 10.1038/sj.bjc.6602447.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cheng TC, Manorek G, Samimi G, Lin X, Berry CC, Howell SB: Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells. Cancer Chemother Pharmacol. 2006, 58 (3): 384-395. 10.1007/s00280-005-0171-8.
Article
CAS
PubMed
Google Scholar
Spentzos D, Levine DA, Kolia S, Otu H, Boyd J, Libermann TA, Cannistra SA: Unique gene expression profile based on pathologic response in epithelial ovarian cancer. J Clin Oncol. 2005, 23 (31): 7911-7918. 10.1200/JCO.2005.02.9363.
Article
CAS
PubMed
Google Scholar
Slonim DK: From patterns to pathways: gene expression data analysis comes of age. Nat Genet. 2002, 32 (Suppl): 502-508. 10.1038/ng1033.
Article
CAS
PubMed
Google Scholar
Curtis RK, Oresic M, Vidal-Puig A: Pathways to the analysis of microarray data. Trends Biotechnol. 2005, 23 (8): 429-435. 10.1016/j.tibtech.2005.05.011.
Article
CAS
PubMed
Google Scholar
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005, 102 (43): 15545-15550. 10.1073/pnas.0506580102.
Article
CAS
PubMed
PubMed Central
Google Scholar
Storey JD, Xiao W, Leek JT, Tompkins RG, Davis RW: Significance analysis of time course microarray experiments. Proc Natl Acad Sci USA. 2005, 102 (36): 12837-12842. 10.1073/pnas.0504609102.
Article
CAS
PubMed
PubMed Central
Google Scholar
Strobel T, Cannistra SA: Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol Oncol. 1999, 73 (3): 362-367. 10.1006/gyno.1999.5388.
Article
CAS
PubMed
Google Scholar
Strobel T, Swanson L, Cannistra SA: In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD44 in the process of peritoneal implantation. Cancer Res. 1997, 57 (7): 1228-1232.
CAS
PubMed
Google Scholar
Tai YT, Strobel T, Kufe D, Cannistra SA: In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene. Cancer Res. 1999, 59 (9): 2121-2126.
CAS
PubMed
Google Scholar
Rieder J, Lirk P, Bodrogi F, Sawires M, Gruber G, Hoffmann G: Cisatracurium, but not mivacurium, induces apoptosis in human umbilical vein endothelial cells in vitro. Eur J Anaesthesiol. 2005, 22 (1): 16-19. 10.1017/S0265021505000049.
Article
CAS
PubMed
Google Scholar
Jones J, Otu H, Spentzos D, Kolia S, Inan M, Beecken WD, Fellbaum C, Gu X, Joseph M, Pantuck AJ, et al: Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res. 2005, 11 (16): 5730-5739. 10.1158/1078-0432.CCR-04-2225.
Article
CAS
PubMed
Google Scholar
Gu X, Zerbini LF, Otu HH, Bhasin M, Yang Q, Joseph MG, Grall F, Onatunde T, Correa RG, Libermann TA: Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells. Cancer Res. 2007, 67 (9): 4219-4226. 10.1158/0008-5472.CAN-06-3689.
Article
CAS
PubMed
Google Scholar
Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003, 4 (2): 249-264. 10.1093/biostatistics/4.2.249.
Article
PubMed
Google Scholar
Pavlidis P, Qin J, Arango V, Mann JJ, Sibille E: Using the gene ontology for microarray data mining: a comparison of methods and application to age effects in human prefrontal cortex. Neurochem Res. 2004, 29 (6): 1213-1222. 10.1023/B:NERE.0000023608.29741.45.
Article
CAS
PubMed
Google Scholar
Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, et al: Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature. 2006, 439 (7074): 353-357. 10.1038/nature04296.
Article
CAS
PubMed
Google Scholar
Spentzos D, Levine DA, Ramoni MF, Joseph M, Gu X, Boyd J, Libermann TA, Cannistra SA: Gene expression signature with independent prognostic significance in epithelial ovarian cancer. J Clin Oncol. 2004, 22 (23): 4700-4710. 10.1200/JCO.2004.04.070.
Article
PubMed
Google Scholar
Bair E, Tibshirani R: Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol. 2004, 2 (4): E108-10.1371/journal.pbio.0020108.
Article
PubMed
PubMed Central
Google Scholar
Varma R, Hector S, Greco WR, Clark K, Hawthorn L, Porter C, Pendyala L: Platinum drug effects on the expression of genes in the polyamine pathway: time-course and concentration-effect analysis based on Affymetrix gene expression profiling of A2780 ovarian carcinoma cells. Cancer Chemother Pharmacol. 2007, 59 (6): 711-723. 10.1007/s00280-006-0325-3.
Article
CAS
PubMed
Google Scholar
Girnun GD, Naseri E, Vafai SB, Qu L, Szwaya JD, Bronson R, Alberta JA, Spiegelman BM: Synergy between PPARgamma ligands and platinum-based drugs in cancer. Cancer Cell. 2007, 11 (5): 395-406. 10.1016/j.ccr.2007.02.025.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mabuchi S, Ohmichi M, Nishio Y, Hayasaka T, Kimura A, Ohta T, Saito M, Kawagoe J, Takahashi K, Yada-Hashimoto N, et al: Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J Biol Chem. 2004, 279 (22): 23477-23485. 10.1074/jbc.M313709200.
Article
CAS
PubMed
Google Scholar
Itoh K, Tong KI, Yamamoto M: Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med. 2004, 36 (10): 1208-1213. 10.1016/j.freeradbiomed.2004.02.075.
Article
CAS
PubMed
Google Scholar
Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, et al: An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997, 236 (2): 313-322. 10.1006/bbrc.1997.6943.
Article
CAS
PubMed
Google Scholar
Motohashi H, Yamamoto M: Carcinogenesis and transcriptional regulation through Maf recognition elements. Cancer Sci. 2007, 98 (2): 135-139. 10.1111/j.1349-7006.2006.00358.x.
Article
CAS
PubMed
Google Scholar
Rincon M, Broadwater G, Harris L, Crocker A, Weaver D, Dressler L, Berry D, Sutton L, Michaelson R, Messino M, et al: Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806. Breast Cancer Res Treat. 2006, 100 (3): 301-308. 10.1007/s10549-006-9251-7.
Article
CAS
PubMed
Google Scholar
Wang TH, Chan YH, Chen CW, Kung WH, Lee YS, Wang ST, Chang TC, Wang HS: Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways. Oncogene. 2006, 25 (35): 4857-4866. 10.1038/sj.onc.1209498.
Article
CAS
PubMed
Google Scholar
Fedier A, Schlamminger M, Schwarz VA, Haller U, Howell SB, Fink D: Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolites. Ann Oncol. 2003, 14 (6): 938-945. 10.1093/annonc/mdg240.
Article
CAS
PubMed
Google Scholar
Kinoshita H, Yoshikawa H, Shiiki K, Hamada Y, Nakajima Y, Tasaka K: Cisplatin (CDDP) sensitizes human osteosarcoma cell to Fas/CD95-mediated apoptosis by down-regulating FLIP-L expression. Int J Cancer. 2000, 88 (6): 986-991. 10.1002/1097-0215(20001215)88:6<986::AID-IJC23>3.0.CO;2-B.
Article
CAS
PubMed
Google Scholar
Ling YH, Donato NJ, Perez-Soler R: Sensitivity to topoisomerase I inhibitors and cisplatin is associated with epidermal growth factor receptor expression in human cervical squamous carcinoma ME180 sublines. Cancer Chemother Pharmacol. 2001, 47 (6): 473-480. 10.1007/s002800000239.
Article
CAS
PubMed
Google Scholar
Basu A, Weixel K, Saijo N: Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells. Cell Growth Differ. 1996, 7 (11): 1507-1512.
CAS
PubMed
Google Scholar
Mohanty S, Huang J, Basu A: Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1. Clin Cancer Res. 2005, 11 (18): 6730-6737. 10.1158/1078-0432.CCR-05-0450.
Article
CAS
PubMed
Google Scholar
Tortora G, Ciardiello F: Antisense strategies targeting protein kinase C: preclinical and clinical development. Semin Oncol. 2003, 30 (4 Suppl 10): 26-31. 10.1016/S0093-7754(03)00282-3.
Article
CAS
PubMed
Google Scholar